跳至主要内容
临床试验/NCT06618768
NCT06618768已完成不适用

Preventive Effect of Aronia Mixture Against UTI - a Pilot Study

University of Agder2 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2022年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
23
试验地点
2
主要终点
Study feasibility: recruitment of participants

研究概览

简要总结

The goal is to determine the feasibility of conducting a randomised clinical trial to measure the effectiveness of an aronia mixture in reducing recurrence of urinary tract infections (UTIs) and antibiotic use by women with a history of frequent UTIs. In addition, the study aim to collect data in order to establish power calculations required for a full-scale study.

详细描述

Aronia berries have been and are used as a food, especially in Eastern Europe and the USA. No negative health effects have been reported from consuming similar amounts of aronia berries as those given to participants in this pilot study. On the contrary, studies suggest that consuming aronia berries has several positive health effects (1). The present 6-months pilot study will examine the feasibility of the study (recruitment process, drop-outs, program adherence, treatment duration, program accetability), identify potential biomarkers of the aronia-mixture and provide information to establish power calculations in a full-scale randomized controlled trial.

Outcomes in the pilot study is number of UTI episodes (both treated and untreated) corresponding to historical episodes (last 12 months), characterization of uropathogens from urine culture analyses, as well as characterization of phenolic metabolites in urine as a result of the intervention. Findings of catabolites based on certain polyphenols will reflect the intestinal ability to metabolize compounds (e.g. condensed tannins), and how these catabolites are absorbed into the circulatory system. Changes in the catabolite pattern will form the basis for estimation of the intervention period needed when planning a full-scale randomized controlled trial.

Research Team:

Tonje H Stea (Professor, University of Agder) - Project Leader Rune Slimestad (Chemist, PhD PlantChem AS) - Responsible for metabolite analysis of urine. Will provide intervention drink and urine containers to the medical office.

Nils Grude (Senior Physician, PhD Antibiotic Center, Ullevål Hospital) - Responsible for microbiology expertise.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • More than 18 years old
  • Recurrent urinary tract infections (rUTI) (minimum of 2 episodes in the last 6 months, or minimum of 3 episodes in the last 12 months).
  • Participants should be cooperative, capable of maintaining a patient diary, and providing urine samples according to a specified schedule.

排除标准

  • Use of Hiprex in the last 6 months.
  • Regular use of aronia in the last 6 months.
  • Allergy to heat-treated aronia or apple.
  • Uncontrolled diabetes mellitus.
  • Use of blood-thinning medication (e.g. Warfarin).

结局指标

主要结局

Study feasibility: recruitment of participants

时间窗: From enrollment to end of treatment at 6 months

Experiences related to the process of recruiting study participants

Study feasibility: drop-outs

时间窗: From enrollment to end of treatment at 6 months

Register the number of dropouts during the intervention period

Study feasibility: program adherence

时间窗: From enrollment to end of treatment at 6 months

Examine adherence to the program by study participants and staff

Study feasibility: duration of the intervention period

时间窗: From enrollment to end of treatment at 6 months

Acceptance of treatment duration among participants and recruiters

次要结局

  • Number of Urinary Tract Infections (UTIs) during the intervention period(From enrollment to end of treatment at 6 months)

研究者

发起方
University of Agder
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tonje Holte Stea

Professor

University of Agder

研究点 (2)

Loading locations...

相似试验